News and Opinions - World Stem Cell Summit

Fat grafts enhanced with ADSCs show promise in treating facial scleroderma

by admin | Apr 19, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Durham, NC – A study released today in STEM CELLS Translational Medicine suggests a new way to correct facial atrophy of localized scleroderma (LoS) in patients. It shows how applying grafts made up of the patient’s own fat enhanced with adipose‐derived stem cells...

Clinical Trial for Novel Investigational Treatment of Type 1 Diabetes Open for Enrollment in Miami

by admin | Apr 8, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Diabetes Research Institute Investigators Will Lead the First Site Activated for the Vertex Study MIAMI, FL – April 6, 2021 – Researchers with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and Vertex Pharmaceuticals...

Stem cell therapy research could help patients with non-healing diabetic foot ulcers

by admin | Apr 7, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Durham, NC – According to the results of a phase 1 clinical trial just published in STEM CELLS Translational Medicine, a new stem cell therapy shows promise of making diabetes-related amputations a thing of the past. The trial involved injecting diabetes patients...

Cell-Based Therapies Show Promise for Seriously Ill Patients with COVID-19

by admin | Mar 26, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Federal Funding for Large-Scale, Randomized, Controlled Trials is Needed to Confirm Results and Help Bring Safe and Effective Treatments to Patients in Need Washington, DC (March 24, 2021) – A new report released by Alliance for Cell Therapy Now, an independent,...

Antioxidant-primed stem cells show promise in repairing bone damaged by radiation

by admin | Mar 22, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Durham, NC – The standard of treatment for bone tumors is often two-fold: surgery to remove the cancerous section followed by raadiation therapy to ensure all the cancerous cells have been killed off. This is an effective way to defeat bone tumors; however, it often...

Longeveron’s Lomecel-B™ Approved by FDA for Compassionate Use for the Treatment of Child with Hypoplastic Left Heart Syndrome (HLHS)

by admin | Mar 16, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

MIAMI, March 11, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced...